Where to Buy Retatrutide: What Is Actually for Sale in 2026
Every route, and where each one stands
| Route | Status on 2 November 2026 | Source |
|---|---|---|
| Pharmacy or prescription | None. Lilly: "an investigational medicine that is not on the market." | Lilly |
| Compounding pharmacy | Not possible. FDA: "Retatrutide and cagrilintide cannot be used in compounding under federal law." | FDA |
| Telehealth or clinic | FDA says it has warned telehealth companies, ingredient distributors and outsourcing facilities over retatrutide. | FDA |
| Clinical trial | The one regulated setting. ClinicalTrials.gov listed 33 studies with retatrutide on 2 November, 2 of them recruiting. Eligibility is set by each trial. | ClinicalTrials.gov |
| Vials labelled for research use | Sold online with no prescription. FDA says companies have illegally sold such products under false research labels. Lilly calls this the black market and has sued sellers. | Lilly, FDA |
Retatrutide for sale: what the stores list today
On 21 November 2026, 3 of the vendors the Bureau reviews listed research-labelled retatrutide vials, from $2.83 to $6.90 per mg in stock, before any code. A listing here is a price record. It is not a statement that a product is safe for people, and these vials are sold for laboratory research. The vial-by-vial table is on retatrutide price today.
| Vendor (Bureau score) | Listed as | Sizes in stock | Lowest per mg | Reader deal | |
|---|---|---|---|---|---|
| Luvaminos (4.1, no independent test held) | Luv RT | 10, 20, 30 mg | $2.83 (30 mg, $85.00) | Code PEPTIDEBUREAU: lower set prices on every single vial (our link applies it) | Check price |
| Aurelia Research (US store) (3.8, no independent test held) | AR-RTA | 10, 20, 30 mg | $4.98 (30 mg, $149.49) | 15% off a first order, applied automatically through our link | Check price |
| Amino Club (4.7, 0 of 1 independent tests passed) | AMP-3 (RT) | 10, 20, 30 mg | $6.33 (30 mg, $189.99) | Code 100: 20% off | Check price |
List prices read from each vendor's own store data on 21 November 2026, before any code. Vendors are ordered by their lowest in-stock price per mg and nothing else. Check price links are affiliate links: the Bureau earns a commission at no cost to you. Limitless Life Peptides, OMNI Peptides and Southern Aminos show prices only after a login or an access request, so they are not in the table. The store data for Apollo Peptide Sciences, Amino USA and Direct Peptides (directpeptides.com) did not answer on 21 November 2026; it comes back on the next read that works. Pantheon Peptides, Ascension Peptides, Sports Technology Labs, Peptide Partners, Penguin Peptides and Ion Peptides listed no single retatrutide vial the Bureau could price on 21 November 2026. These are vials sold for research use, not a pharmacy product, and a listing here is not a statement that a product is safe for people.
Best vendor for Retatrutide
Amino Club
Bureau Score 4.7 · 0 of 1 independent tests passed · Read the review
- Lab proof: Batch COA on every product page from an 8-assay panel at ILS Laboratories.
- Price: From $6.67 per mg: $199.99 for a 30 mg vial, list price read 1 November 2026, before any code.
- Shipping: Ships from the US to all 50 states, free standard shipping over $100, 1 to 4 business days.
- Listed as: AMP-3 (RT), the name this store sells it under.
Code 100: 20% off
Why the label may not say retatrutide
Some stores list it under a code: AMP-3 (RT) at Amino Club, Luv RT at Luvaminos, AR-RTA at Aurelia Research, GLP-3 R at Apollo. The Bureau's reviews tie those codes to the compound. Lilly calls "GLP-3" a "scientifically inaccurate label", so the code proves nothing on its own. Look for the compound's name on the certificate for your lot.
What can be checked before an order, and what cannot
No regulator releases these batches and no recall system stands behind them. A certificate is the store's own evidence, so the useful checks are about whether that evidence holds up. Passing all of them does not make a vial safe for a person.
- The certificate matches the lot. The lot number on the document should match the one on the vial. A generic purity claim on a store page is not a certificate.
- The lab can confirm it. Some labs let anyone look up a report with a key on the lab's own site. Check there, not on a copy hosted by the store. A confirmed key is not the end of it: on 2 November the Bureau found two Janoshik retatrutide reports, one for nexaph.com and one for ameanopeptides.com, with the same dates and figures to the third decimal. So a report under a store's name does not prove that store's own vial was tested.
- It tests identity as well as purity. A high purity figure does not show which compound is in the vial. Australia's regulator found a product labelled retatrutide with none in it and undeclared semaglutide, ABC News reported. Our peptide testing guide explains what each test shows.
- Someone other than the store has tested it. See the table below. Few stores have more than a handful of results.
- The store's terms and record. Returns, any FDA letters and complaints are in each review on the 2026 scorecard, with more steps in how to buy peptides.
Independent tests of retatrutide, by store
| Store | Finnrick retatrutide rating | Tests |
|---|---|---|
| NexaPh | 75% | 105 |
| Polaris Peptides | 77% | 29 |
| Limitless | 70% | 5 |
| Amino Club | 74% | 1 |
| Apollo Peptide Sciences | 74% | 1 |
| Luvaminos | none yet | 0 |
| Ascension Peptides | none yet | 0 |
Read on 2 November 2026 from Finnrick's vendor pages, whose current method looks for purity of 99.5% or more and a dose within 35% of the label. Across all compounds Finnrick counted 0 of 1 classifiable tests passed for Amino Club, 0 of 4 for Apollo and 7 of 23 for Limitless Life Nootropics. One test is not a track record. We found no Finnrick page for PSPeptides or Aurelia Research. NexaPh and Polaris are in the table for their long records; the Bureau has no program with them and scores them low on other grounds in their reviews.Checkout paused since 20 Nov 2026; the store says orders reopen soon.
Not sure which of these you actually need?
Answer five questions about your goal, experience and budget and the Stack Builder shows you a matched research protocol on screen, with the compounds and vendor picks from the vendors we score.
Build your stack, 2 minutesWhen could it be bought legally?
Not before approval. Lilly says launch "will depend on the completion of these trials and the regulatory approval process", and on 29 September 2026 it said it plans to file with FDA in the first quarter of 2027. A filing is not an approval. It is too early to quote a date or a price; what Lilly has said on price is on retatrutide price today.
Tirzepatide, a different drug from the same company, is approved as Mounjaro and Zepbound and can be had on a prescription; the routes are in where to buy tirzepatide. Harm reports and lawsuits around retatrutide are in our report on the black market. This page gives no dosing advice; for vial arithmetic, use the retatrutide calculator at Peptulator.
Reader deals at the stores in the table
Links may earn the Bureau a commission at no cost to you; that is not an input to any score. The order of stores in our buying blocks, including the Best vendor label, is our own choice and is not the score; some of those stores pay us commission. A code changes the price, not what is in the vial. Research use only.
- Luvaminos, 4.1 (no independent test held): Code PEPTIDEBUREAU: lower set prices on every single vial (our link applies it). Bureau notes.
- Aurelia Research (US store), 3.8 (no independent test held): 15% off a first order, applied automatically through our link. Bureau notes.
- Amino Club, 4.7 (0 of 1 independent tests passed): Code 100: 20% off. Bureau notes.
Every compound, every morning: the peptide price tracker. Working codes: peptide coupon codes. How stores are scored: the 2026 scorecard.
Vendor Watch · free
Know before you order: an email when a vendor we cover is shut down, seized, fails a lab test or changes its code.
Plus, every Friday, the week's lowest price per mg for each compound at the vendors we score, all of which publish batch COAs. Your 5-minute vendor check sheet opens as soon as you confirm.
Every alert is checked by a person and cites its source before it is sent. One-click unsubscribe. Research use only.
Frequently Asked Questions
Where can you buy retatrutide?
No pharmacy, doctor or compounder can supply an approved product, because none exists. Retatrutide is available in regulated form only inside clinical trials. Online stores sell vials labelled for research use; FDA says such labels are false on products sold as drugs and urges consumers not to buy them.
Is it legal to buy retatrutide?
FDA and Lilly address the sale: Lilly says no one can legally sell it for human use and that FDA has made clear sales of unapproved retatrutide to consumers are illegal. We found no statement from either on buyers themselves. The Bureau is not a law firm, so take legal questions to a lawyer in your country.
Can a doctor prescribe retatrutide?
No. It has no approval, so there is no prescription product. FDA also says retatrutide cannot be used in compounding under federal law, and it has warned telehealth companies over it.
How do you join a retatrutide clinical trial?
Search ClinicalTrials.gov, where each listing sets out its own eligibility and contacts. On 2 November 2026 it showed 33 studies with retatrutide, 2 of them recruiting. Lilly runs the Phase 3 programs.
When will retatrutide be available?
No date exists. Lilly said on 29 September 2026 that it plans to file for FDA approval in the first quarter of 2027, and that launch depends on completing the trials and regulatory review.
Is GLP-3 the same as retatrutide?
Stores use GLP-3 R and similar names as product codes for retatrutide. Lilly calls GLP-3 a scientifically inaccurate label for a triple agonist. A code proves nothing on its own, so look for the compound's name on the certificate for your lot.
Is a research vial of retatrutide safe for people?
No one can say that it is. No regulator has reviewed these vials. Lilly warns they may hold unknown ingredients, contaminants, too much or too little active ingredient, or the wrong ingredient entirely, and FDA says they may be harmful.
Sources
- Lilly, What to know about retatrutide, updated October 2026. Read 2 November 2026.
- Lilly, Lilly calls on online platforms, payment companies and regulators to shut down the illegal retatrutide black market, 12 August 2026. Read 2 November 2026.
- Lilly, TRIUMPH-2 results and BLA plan, 29 September 2026. Read 2 November 2026.
- FDA, FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss, content current as of 1 October 2026. Read 2 November 2026.
- ClinicalTrials.gov, studies with retatrutide as an intervention. Read 2 November 2026.
- ABC News, Patient suffers torn oesophagus after using unapproved peptide, 14 September 2026.
- Finnrick vendor pages for Amino Club, Apollo Peptide Sciences, Limitless Life Nootropics, LUV Aminos and Ascension Peptides, read 2 November 2026. NexaPh and Polaris figures are from our reviews of the same date.
- Peptide Bureau daily price tracker, list prices read 21 November 2026, before any code.